查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1963922

人工水晶体市场－全球产业规模、份额、趋势、机会和预测：按产品、最终用户、地区和竞争对手划分，2021-2031年

Intraocular Lens Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End user, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球人工水晶体市场预计将从 2025 年的 47.9 亿美元成长到 2031 年的 62.4 亿美元，复合年增长率达到 4.51%。

这些人工植入旨在白内障手术中替代眼球的天然水晶体，对于恢復清晰视力至关重要。其成长主要受全球人口快速老化驱动，而人口老化又与白内障患病率上升以及对有效视力恢復治疗需求激增直接相关。此外，患者对无眼镜视力恢復的偏好也发生了显着变化，推动了具有多焦点功能的先进晶状体技术的应用。为了佐证人们对更佳视觉效果的需求，欧洲屈光和屈光手术学会报告称，在其调查的会员中，2024年同时进行视力调节的人工水晶体植入率达到了16%。

市场概览
预测期 2027-2031
市场规模：2025年 47.9亿美元
市场规模：2031年 62.4亿美元
复合年增长率：2026-2031年 4.51%
成长最快的细分市场 多焦点人工水晶体
最大的市场 北美洲

儘管前景光明，但经济壁垒仍是市场扩张的主要障碍。除了高端隐形眼镜价格昂贵之外，不同医疗体系报销政策的不一致也导致许多患者无法获得这些先进的治疗方案。因此，许多患者只能选择标准单焦点隐形眼镜，这限制了高端市场的获利能力，尤其是在价格敏感型地区。

市场驱动因素

白内障和老龄化眼科疾病的日益普遍是推动市场成长的主要催化剂，全球范围内的手术量也因此大幅增加。随着人口老化，水晶体混浊的发生率不断上升，需要进行扩充性且频繁的修復手术来预防视力丧失。这一人口趋势直接支撑了主要医疗设备製造商的持续收入成长，凸显了疾病负担与市场需求之间的关联性。例如，爱尔康公司在2025年2月发布的年度报告中指出，其2024财年全年手术相关净销售额达到55亿美元，反映了全球对眼科手术产品的旺盛需求。同样，卡尔蔡司医疗技术公司在2025年12月宣布，其眼科策略业务部门在2024/25财年的收入达到17.2亿欧元，进一步证明了该行业的庞大规模。

第二个关键驱动因素是高阶和多焦点人工水晶体（IOL）的技术进步，这使得价值的焦点从单纯的手术次数转向更卓越的视觉效果。外科医生和患者都越来越倾向于选择超越单焦点晶状体的功能，这种晶状体可以消除对眼镜的依赖，并矫正老花眼和散光。这一趋势推动了景深扩展（EDOF）和三焦点技术的应用，从而导致更高的价格和更多元化的收入来源。例如，强生公司在2025年1月发布的报告显示，其医疗技术部门2024年第四季的视觉相关产品销售额成长了7.9%。 TECNIS PureSee和Eyhance等人工水晶体的商业性成功尤其提振了手术领域的表现。

市场挑战

全球人工水晶体市场在很大程度上受到持续存在的经济障碍的限制，这些障碍限制了患者获得先进技术的机会。儘管临床上对无需佩戴眼镜的多焦点和高端人工水晶体有着明显的需求，但这些植入相关的高昂自付费用却让相当一部分潜在患者望而却步。在许多医疗保健系统中，保险报销模式仅涵盖标准单焦点人工水晶体，迫使患者承担升级到高端人工水晶体的全部费用。这种价格差异造成了市场两极化，在价格敏感的地区，低利润的基础产品占据了主导地位，有效地抑制了该行业的潜在价值成长。

此外，白内障手术报销率的波动加剧了这项挑战，挤压了眼科诊所的营运利润，降低了他们推荐高端手术方案的意愿。 2024年，美国眼科学会宣布，美国医疗保险和医疗补助服务中心（CMS）已将医生报销比例降低了3.37%。报销资金的减少给手术提供者带来了额外的经济负担，使他们越来越难以维持额外的咨询时间和行政资源，从而难以向患者解释和提供高成本的高端晶体技术，这直接阻碍了市场收入的成长。

市场趋势

术后光可调人工晶体（LAL）系统的商业化正在从根本上改变屈光矫正的精准度，解决了人工晶体有效植入和癒合反应的不确定性。与需要精确术前预测的固定式高端人工晶体不同，这些系统允许外科医生使用紫外线照射治疗来调节植入人工晶体的屈光。这不仅可以矫正残余屈光不正，还能提供每位患者个人化的视觉效果。这项技术正迅速受到医疗机构的青睐，这些机构希望降低意外屈光不正的风险并儘量减少再次手术。 RxSight公司截至2025年2月的财年财务数据显示，2024年全年销售额将达到1.399亿美元，年增57%，凸显了临床对这项可调可用技术的日益增长的需求。

同时，用于矫正高度近视的有晶体眼人工晶体（Phakic IOL）市场的扩张表明，对于不适合接受角膜雷射手术的年轻患者，屈光矫正方案正朝着基于晶体的方案转变。这一趋势的特征是可植入式胶原蛋白晶体（ICL）的使用日益增加。 ICL是一种可逆的手术方式，可以取代LASIK和PRK，在矫正严重屈光不正的同时保留眼球的天然晶状体。在传统重点区域之外，ICL市场成长尤其强劲，凸显了此方法作为主要屈光矫正方案的有效性。根据STAAR Surgical发布的2025财年报告，除中国以外，ICL（可植入式胶原蛋白晶体）的季度销售额达到3,950万美元，较去年同期成长17%。这表明该治疗方法在全球范围内的接受度正在不断提高。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球人工水晶体市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品类别（单人工水晶体、多焦点人工水晶体、散光人工水晶体、IOCT人工水晶体）
    • 依最终使用者（医院/诊所、门诊中心、其他）划分
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美人工水晶体市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲人工水晶体市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区人工水晶体市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲人工水晶体市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲人工水晶体市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球人工水晶体市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Alcon, Inc.
  • Johnson and Johnson
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Rayner Group
  • EyeKon Medical, Inc.
  • Lenstec, Inc.
  • HumanOptics AG
  • STAAR Surgical Company
  • Hoya Corporation

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 19354

The Global Intraocular Lens Market is projected to expand from USD 4.79 Billion in 2025 to USD 6.24 Billion by 2031, achieving a compound annual growth rate of 4.51%. Designed to replace the natural lens of the eye, typically during cataract surgery, these artificial implants are essential for restoring clear vision. This growth is primarily fueled by a rapidly aging global demographic, which directly correlates with a higher prevalence of cataracts and a surging need for effective restorative interventions. Furthermore, there is a noticeable shift in patient preference toward achieving spectacle independence, driving the uptake of advanced lens technologies with multifocal features. Highlighting this demand for superior visual outcomes, the European Society of Cataract and Refractive Surgeons reported a 16% conversion rate for simultaneous vision intraocular lenses among surveyed members in 2024.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 4.79 Billion
Market Size 2031USD 6.24 Billion
CAGR 2026-20314.51%
Fastest Growing SegmentMultifocal intraocular lens
Largest MarketNorth America

Despite this promising outlook, economic hurdles continue to pose a major obstacle to widespread market development. The high expense associated with premium lenses, combined with uneven reimbursement policies across various healthcare frameworks, often restricts patient access to these sophisticated treatment alternatives. As a result, a significant number of individuals are confined to standard monofocal lenses, a factor that limits the revenue potential of the premium segment, particularly in price-sensitive regions.

Market Driver

The escalating prevalence of cataracts and age-related eye conditions acts as the primary catalyst for market growth, necessitating a substantial global increase in surgical volumes. As the elderly population grows, the frequency of lens opacification increases, requiring scalable and frequent restorative procedures to avert vision loss. This demographic trend directly supports sustained financial gains for leading device manufacturers, confirming the link between disease burden and market demand. For instance, Alcon reported in its February 2025 Annual Report that surgical net sales hit $5.5 billion for the full year 2024, reflecting strong global demand for ophthalmic surgical products. Similarly, Carl Zeiss Meditec AG announced in December 2025 that its Ophthalmology Strategic Business Unit achieved revenues of €1.72 billion for the 2024/25 fiscal year, further demonstrating the sector's vast scale.

A second pivotal driver is the technological progression in premium and multifocal intraocular lenses (IOLs), which shifts the value focus from mere procedural volume to superior visual results. Both surgeons and patients are increasingly favoring lenses that provide spectacle independence and correct conditions like presbyopia or astigmatism, moving beyond basic monofocal solutions. This preference fuels the adoption of Extended Depth of Focus (EDOF) and trifocal technologies, which command higher prices and diversify revenue streams. Illustrating this trend, Johnson & Johnson reported in January 2025 that vision sales within its MedTech segment rose by 7.9% in the fourth quarter of 2024, with surgical performance specifically boosted by the commercial success of innovations like the TECNIS PureSee and Eyhance intraocular lenses.

Market Challenge

The expansion of the Global Intraocular Lens Market is significantly constrained by persistent economic barriers that limit patient access to advanced technologies. While there is a clear clinical demand for multifocal and premium lenses that facilitate spectacle independence, the substantial out-of-pocket costs associated with these implants discourage a large portion of the potential patient base. In many healthcare systems, reimbursement models only cover standard monofocal lenses, leaving patients to cover the entire financial difference for premium upgrades. This price disparity creates a divided market where adoption is heavily skewed toward basic, lower-revenue products in price-sensitive areas, effectively capping the industry's potential value growth.

Additionally, fluctuations in reimbursement rates for cataract procedures exacerbate this challenge by tightening the operational margins of ophthalmic practices, thereby disincentivizing the promotion of premium options. In 2024, the American Academy of Ophthalmology noted that the Centers for Medicare & Medicaid Services implemented a 3.37% reduction in the physician fee schedule conversion factor. This decline in reimbursement funding places further financial strain on surgical providers, making it increasingly difficult to sustain the extra chair time and administrative resources required to educate patients on and deliver high-cost premium lens technologies, directly stalling market revenue growth.

Market Trends

The commercialization of Post-Operative Light-Adjustable Lens (LAL) Systems is fundamentally transforming the refractive accuracy landscape by addressing the unpredictability of effective lens position and healing responses. Unlike static premium lenses that require precise pre-operative estimation, these systems allow surgeons to modify the lens power after implantation using UV light treatments, thereby correcting residual refractive errors and delivering customized visual profiles. This capability has driven rapid uptake among practices seeking to mitigate the risk of refractive surprises and minimize enhancement procedures. According to RxSight, Inc.'s February 2025 financial results, full-year 2024 revenue reached $139.9 million, marking a 57% increase over the previous year, highlighting the surging clinical demand for this adjustable technology.

Simultaneously, the expansion of the Phakic IOL Market for High Myopia Correction represents a strategic shift toward lens-based refractive solutions for younger patients who are unsuitable for corneal laser procedures. This trend is characterized by the increasing utilization of implantable collamer lenses that preserve the eye's natural crystalline lens while correcting severe refractive errors, offering a reversible alternative to LASIK or PRK. Market growth is particularly robust in regions where adoption is diversifying beyond traditional strongholds, validating the modality as a primary option for refractive correction. According to STAAR Surgical's February 2025 report, Implantable Collamer Lens (ICL) sales excluding the Chinese market reached $39.5 million for the quarter, an increase of 17% compared to the prior year period, evidencing the widening global acceptance of this therapeutic class.

Key Market Players

  • Alcon, Inc.
  • Johnson and Johnson
  • Bausch & Lomb Incorporated
  • Carl Zeiss Meditec AG
  • Rayner Group
  • EyeKon Medical, Inc.
  • Lenstec, Inc.
  • HumanOptics AG
  • STAAR Surgical Company
  • Hoya Corporation

Report Scope

In this report, the Global Intraocular Lens Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Intraocular Lens Market, By Product

  • Monofocal Intraocular Lens
  • Multifocal Intraocular Lens
  • Toric Intraocular Lens
  • Accommodative Intraocular Lens

Intraocular Lens Market, By End user

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

Intraocular Lens Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Intraocular Lens Market.

Available Customizations:

Global Intraocular Lens Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Intraocular Lens Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Monofocal Intraocular Lens, Multifocal Intraocular Lens, Toric Intraocular Lens, Accommodative Intraocular Lens)
    • 5.2.2. By End user (Hospitals & Clinics, Ambulatory Care Centers, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Intraocular Lens Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End user
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Intraocular Lens Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End user
    • 6.3.2. Canada Intraocular Lens Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End user
    • 6.3.3. Mexico Intraocular Lens Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End user

7. Europe Intraocular Lens Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End user
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Intraocular Lens Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End user
    • 7.3.2. France Intraocular Lens Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End user
    • 7.3.3. United Kingdom Intraocular Lens Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End user
    • 7.3.4. Italy Intraocular Lens Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End user
    • 7.3.5. Spain Intraocular Lens Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End user

8. Asia Pacific Intraocular Lens Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End user
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Intraocular Lens Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End user
    • 8.3.2. India Intraocular Lens Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End user
    • 8.3.3. Japan Intraocular Lens Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End user
    • 8.3.4. South Korea Intraocular Lens Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End user
    • 8.3.5. Australia Intraocular Lens Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End user

9. Middle East & Africa Intraocular Lens Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End user
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Intraocular Lens Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End user
    • 9.3.2. UAE Intraocular Lens Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End user
    • 9.3.3. South Africa Intraocular Lens Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End user

10. South America Intraocular Lens Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End user
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Intraocular Lens Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End user
    • 10.3.2. Colombia Intraocular Lens Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End user
    • 10.3.3. Argentina Intraocular Lens Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End user

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Intraocular Lens Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Alcon, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Johnson and Johnson
  • 15.3. Bausch & Lomb Incorporated
  • 15.4. Carl Zeiss Meditec AG
  • 15.5. Rayner Group
  • 15.6. EyeKon Medical, Inc.
  • 15.7. Lenstec, Inc.
  • 15.8. HumanOptics AG
  • 15.9. STAAR Surgical Company
  • 15.10. Hoya Corporation

16. Strategic Recommendations

17. About Us & Disclaimer